Temporal (Circadian) and Functional Relationship Between Atrial Natriuretic Peptides and Blood Pressure

References

• DeBold AJ, Borenstein HB, Veress AT, et al. A rapid and potent natriuretic response to intravenous injection of the myocardial extract in rats. Life Sci 1981; 28: 89–94
   PubMed Web of Science ®Google Scholar
• Currie MG, Geller DM, Cole BR, et al. Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science 1983; 221: 71–3
   PubMed Web of Science ®Google Scholar
• Vesely DL, Norris JS, Walters JM, et al. Atrial natriuretic prohormone peptides 1–30, 31–67, and 79–98 vasodilate the aorta. Biochem Biophys Res Commun 1987; 148: 1540–8
   PubMed Web of Science ®Google Scholar
• Martin DR, Pevahouse JB, Trigg DJ, et al. Three peptides from the ANF prohormone NH2-terminus are natriuretic and/or kaliuretic. Am J Physiol 1990; 258: F1401–8
   Google Scholar
• Vesely DL, Douglass MA, Dietz JR, et al. Two peptides from the atrial natriuretic factor prohormone amino terminus produce a significant natriuresis and diuresis in humans. Cl in Res 1993; 41: 117A
   Google Scholar
• Vesely DL, Douglass MA, Dietz JR, et al. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, natriuresis, and/or kaliuresis in humans. Circulation 1994; 90: 1129–40
   PubMed Web of Science ®Google Scholar
• Vesely DL, Douglass MA, Dietz JR, et al. Negative feedback of atrial natriuretic peptides. J Clin Endocrinol Metab 1994; 78: 1128–34
   PubMedGoogle Scholar
• Sugawara A, Nakao K, Sakamoto M, et al. Plasma concentration of atrial natriuretic polypeptide in essential hypertension. Lancet 1985; ii: 1426–7
   Google Scholar
• Arendt R, Gerbes A, Ritter D, et al. Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. J Hypertens 1986; 4(suppl 2)131–5
   Google Scholar
• Sagnella GA, Markandu ND, Shore AC, et al. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1986; i: 179–81
   Google Scholar
• Vesely DL. Atrial natriuretic hormones. Prentice-Hall, Englewood Cliffs, NJ 1992; 1–256
   Google Scholar
• Merkouris RW, Miller FC, Catanzarite V, et al. The N-terminal and C-terminal portions of the atrial natriuretic factor prohormone increase during preeclampsia. Am J Obstet Gynecol 1991; 164: 1197–1202
   PubMedGoogle Scholar
• Vesely DL, Arnold WC, Winters CJ, et al. Increased circulating concentration of atrial natriuretic factor in persons with pheochromocytomas. Clin Exp Hypertens [A] 1989; 11: 353–69
   PubMed Web of Science ®Google Scholar
• Vesely DL, Arnold WC, Winters CJ, et al. Increased circulating concentration of the N-terminus of the atrial natriuretic factor prohormone in persons with pheochromocytomas. J Clin Endocrinol Metab 1990; 71: 1138–46
   PubMed Web of Science ®Google Scholar
• McMurray RW, Jr, Vesely DL. Weight reduction decreases atrial natriuretic factor and blood pressure in obese patients. Metabolism 1989; 38: 1231–7
   PubMed Web of Science ®Google Scholar
• McMurray RW, Jr, Vesely DL. Weight reduction decreases the circulating concentration of the N-terminus of the ANF prohormone. Am J Med Sci 1992; 303: 2–8
   PubMedGoogle Scholar
• Maoz E, Shamiss A, Peleg E, et al. The role of atrial natriuretic peptide (ANP) in natriuresis of fasting. Int Soc Hypertens, (in press)
   Google Scholar
• Winters CJ, Sallman AL, Vesely DL. Circadian rhythm of prohormone atrial natriuretic peptides 1–30, 31–67, and 99–126 in man. Chronobiol Int 1988; 5: 403–9
   PubMed Web of Science ®Google Scholar
• Vesely DL, Kanabrocki EL, Sothern RB, et al. The circadian rhythm of the N-terminus and C-terminus of the atrial natriuretic factor prohormone. Chronobiol Int 1990; 7: 51–7
   PubMed Web of Science ®Google Scholar
• Bristow JD, Honour AJ, Pickering TW, et al. Cardiovascular and respiratory changes during sleep in normal and hypertensive subjects. Cardiovasc Res 1969; 3: 476–85
   PubMed Web of Science ®Google Scholar
• Reinberg A, Ghata J, Halberg F, et al. Rhythmes circadiens du pouls, de la pressin arterielle, des excretion urinaires en 17-hydroxycorticosteroides, catecholamines et potassium chez l'homme adulte sain, active et au repos. Ann Endocrinol 1970; 31: 277–87
   PubMed Web of Science ®Google Scholar
• Sothern RB, Vesely DL, Kanabrocki EL, et al. Blood pressure and atrial natriuretic peptides correlate through-out the day. Am Heart J 1995; 129, (in press)
   Google Scholar
• Kanabrocki EL, Sothern RB, Scheving LE, et al. Reference values for circadian rhythms of 98 variables in clinically healthy men in fifth decade of life. Chronobiol Int 1990; 7(5/6)445–61
   PubMed Web of Science ®Google Scholar
• Winters CJ, Sallman AL, Baker BJ, et al. The N-terminus and a 4000 molecular weight peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in man and increase in congestive heart failure. Circulation 1989; 80: 438–49
   PubMed Web of Science ®Google Scholar
• Vesely DL, Gower WR, Jr, Giordano AT, et al. Atrial natriuretic peptides in the heart and hemolymph of the oyster, Crassostrea virginica: a comparison with vertebrates. Comp Biochem Physiol 1993; 106B: 535–46
   Google Scholar
• Gower WR, Jr, Chiou S, Skolnick K, et al. Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 1994; 15: 861–7
   PubMed Web of Science ®Google Scholar
• Vesely DL, Norsk P, Winters CJ, et al. Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans. Proc Soc Exp Biol Med 1989; 192: 230–5
   PubMed Web of Science ®Google Scholar
• Nelson W, Tong Y-L, Lee J-K, et al. Methods for cosinor-rhythmometry. Chronobiologia 1979; 6: 305–23
   PubMedGoogle Scholar
• Bingham C, Arbogast B, Guillaume GC, et al. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 1982; 9: 397–439
   PubMedGoogle Scholar
• Nelson W, Cornélissen G, Hinkley D, et al. Construction of rhythm-specified reference intervals and regions, with emphasis on “hybrid” data, illustrated for plasma cortisol. Chronobiologia 1983; 10: 179–93
   PubMedGoogle Scholar
• Ngo L, Vesely DL, Bissett JK, et al. Acute and sustained release of atrial natriuretic factor with acute myocardial infarction. Am Heart J 1989; 118: 893–900
   PubMed Web of Science ®Google Scholar
• Ngo L, Vesely DL, Bissett JK, et al. Acute and sustained release of the atrial natriuretic factor prohormone N-terminus with acute myocardial infarction. Am J Med Sci 1991; 301: 157–64
   PubMedGoogle Scholar
• Portaluppi F, Vergnani L, Degli U, et al. Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach. Chronobiol Int 1993; 10: 176–89
   PubMed Web of Science ®Google Scholar
• Yanagisawa M, Akihiro I, Ishikawa T, et al. Primary structure, synthesis and biological activity of rat endothelin, and endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 1988; 85: 6964–7
   PubMed Web of Science ®Google Scholar
• Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–5
   PubMed Web of Science ®Google Scholar
• Fukuda Y, Hirata Y, Taketani S, et al. Endothelin stimulates accumulation of cellular atrial natriuretic peptide and its messenger RNA in rat cardiocytes. Biochem Biophys Res Commun 1989; 164: 1431–6
   PubMed Web of Science ®Google Scholar
• Saito Y, Nakao K, Mukoyama M, et al. Increased plasma endothelin level in patients with essential hypertension [Letter(. N Engl J Med 1990; 322: 205
   PubMed Web of Science ®Google Scholar